This is the video recording of the November 15, 2023, Hot Corner Insider Weekly Strategy Session.

Today, a "darling" company in the media thanks to new obesity drugs and other good news hitting the media airwaves is selling off. In fact, its having its worst day relative to its sector peers in many years.

Someone forgot to tell Eli Lilly $LLY that a new bull market run may recently have gotten under way. Of course, it was already way ahead of the game. In fact, look at this long-term chart:

These aren't usually the trends I like to take the other side of.

But perhaps it's gone on a little too long and it's ready to pause and retrace?

This stock could get cut in half and the long-term trend would still be intact.

When we zoom in a little closer, we see a very notable (and sizeable) gap from this summer where the stock jumped from $450 per share to north of $500 per share overnight:

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Baker Bros Advisors LLC.

The hedge fund revealed a purchase of Madrigal Pharmaceuticals, Inc $MDGL worth $23 million.

In today's Daily Digest, we'll review:

1. Any new position added today
2. Adjustment made to an existing position (if any)
3. Any exits since last report
4. Current status of open campaigns.

Let's dig in!

From the Desk of Steve Strazza and Alfonso Depablos

Today’s most significant insider transaction comes in a Form 4 filing by Decheng Capital Management, a hedge fund focused on investing in early-stage life science companies.

Decheng reported a purchase in the biotech company Alpine Immune Sciences $ALPN worth more than $4.6 million.

This is the best time of the year for stocks.

And stocks are doing very well.

In other words, perfectly normal market behavior.

In fact, this is exactly when Small-caps historically start to outperform their large-cap counterparts.

And sure enough, that's exactly what we're seeing.

Here's a great chart from Jeff Hirsch and Jay Kaeppel showing these seasonal tendencies:

From the Desk of Ian Culley @IanCulley

Miami is pure gold.

It sways to its own beat, enticing and intoxicating even the insular traveler.

Incidentally, I was engulfed by the city’s rhythm as I attended a family wedding last weekend.

And it was wild!

I danced with family and friends and sipped bubbles at sunset in Key Biscayne straight through to the early morning hours along South Beach.

But this old dog would never have made it to dawn without my wife’s crazy cousins. 

They displayed an appetite for reckless abandon that gold longs to witness from its own crazy cousin…

From the Desk of Steve Strazza and Alfonso Depablos

Today’s most significant insider transaction comes in a Form 4 filing by Decheng Capital Management, a hedge fund focused on investing in early-stage life science companies.

Decheng reported a purchase in the biotech company Alpine Immune Sciences $ALPN worth more than $4.6 million.

In today's Daily Digest, we'll review:

1. Any new position added today
2. Adjustment made to an existing position (if any)
3. Any exits since last report
4. Current status of open campaigns.

Let's dig in!

From the Desk of Ian Culley @IanCulley

Miami is pure gold.

It sways to its own beat, enticing and intoxicating even the insular traveler.

Incidentally, I was engulfed by the city’s rhythm as I attended a family wedding last weekend.

And it was wild!

I danced with family and friends and sipped bubbles at sunset in Key Biscayne straight through to the early morning hours along South Beach.

But this old dog would never have made it to dawn without my wife’s crazy cousins. 

They displayed an appetite for reckless abandon that gold longs to witness from its own crazy cousin…

Silver!

Gold wants to party like a rock star until the wee hours as it twists and turns toward a new all-time high.

Unfortunately, silver doesn’t want to dance.

Check out gold futures overlaid with the silver-to-gold ratio:

The silver-to-gold ratio can’t find its feet. Instead, it remains glued to a shelf of former lows.

Silver needs to make its way to the dance floor if gold has any chance of reaching a new high. But silver must not only participate, it must take the lead.

Money flows to the riskier areas of...

From the Desk of Steve Strazza and Alfonso Depablos

Today’s most significant insider transaction comes in a Form 4 filing by Block $SQ director Roelof Botha.

Botha reported a $27 million purchase of SQ shares.

From the desk of Steve Strazza @Sstrazza.

Welcome back to Under the Hood, where we'll cover all the action for the week ended November 11, 2023. This report is published bi-weekly and rotated with The Minor Leaguers.

What we do here is analyze the most popular stocks during the week and find opportunities to either join in and ride these momentum names higher, or fade the crowd and bet against them.

We use a variety of sources to generate the list of most popular names.

There are so many new data sources available that all we need to do is organize and curate them in a way that shows us exactly what we want: a list of stocks seeing an unusual increase in investor interest.

Click here for a behind-the-scenes look at our process.

Whether we’re measuring increasing interest based on large institutional purchases, unusual options activity, or simply...

From the Desk of Steve Strazza @sstrazza and Alfonso Depablos @Alfcharts

This is one of our favorite bottom-up scans: Follow the Flow.

In this note, we simply create a universe of stocks that experienced the most unusual options activity — either bullish or bearish, but not both.

We utilize options experts, both internally and through our partnership with The TradeXchange. Then, we dig through the level 2 details and do all the work upfront for our clients.

Our goal is to isolate only those options market splashes that represent levered and high-conviction, directional bets.

We also weed out hedging activity and ensure there are no offsetting trades that either neutralize or cap the risk on these unusual options trades.

What remains is a list of stocks that large financial institutions are putting big money behind.

And they’re doing so for one reason only: because they think...

This is definitely a "hard" trade. Hard because it's already had a tremendous run this month. Hard because it's in a name that people often don't associate with big bull runs, in a sector that definitely isn't sexy.

And maybe we're early, positioning just about when it's about to take a pause or retrace to digest recent gains. Maybe.

The only way to find out is to get involved.

The hard trades pay precisely because they are hard.

In today's Daily Digest, we'll review:

1. Any new position added today
2. Adjustment made to an existing position (if any)
3. Any exits since last report
4. Current status of open campaigns.

Let's dig in!

Technical Analysis is the study of the behavior of the market, and therefore market participants.

We're analyzing how humans behave.

That's the edge that a good technician has over other types of investors.

Conditions change. Market environments go through different cycles. But the humans act in similar ways.

From the Desk of Steve Strazza and Alfonso Depablos

Today’s most significant insider transaction comes in a Form 4 filing by Block $SQ director Roelof Botha.

Botha reported a $27 million purchase of SQ shares.